ProCE Banner Activity

Medical Minute on Key Decisions in HIV Care: Treatment Considerations for Transgender PWH

Multimedia
In this case example, learn some of the key considerations for ART management for transgender PWH including providing care within a gender-affirmative care model, considering drug-drug interactions between hormone therapy and ART, and addressing barriers to engagement and retention in care.

Released: April 18, 2022

Expiration: April 17, 2023

Share

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS

Associate Professor of Pediatrics
Division of Pediatric Infectious Diseases
Medical Director
Montefiore Adolescent and Youth Sexual-Health Clinic
Pediatric and Adolescent HIV
Children's Hospital at Montefiore
Pediatric Hospital of Albert Einstein College of Medicine
Bronx, New York

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, has no relevant conflicts of interest to report.